Krupka Michal, Matusu Tereza, Sutova Helena, Wezdenkova Katerina, Vecerova Renata, Smesna Yvona, Kolar Milan, Frankova Hana Bilkova, Krivankova Jana, Jorenek Miroslav, Novak Zdenek, Raska Milan, Holy Ondrej
Department of Immunology, Faculty of Medicine and Dentistry, Palacky University Olomouc, 775 15 Olomouc, Czech Republic.
Mikrochem Laboratories a.s., 779 00 Olomouc, Czech Republic.
Vaccines (Basel). 2022 Jan 25;10(2):185. doi: 10.3390/vaccines10020185.
Although the incidence of measles has decreased globally since the introduction of regular vaccination, its frequency has increased again in recent years. The study is focused on data from the Olomouc Region in the Czech Republic analyzed in four laboratories. The obtained results were compared with already published data.
The data were provided by individual laboratories in an anonymized form-age at the time of the examination, sex, and result of test. Samples were collected between June 2018 and September 2019 and evaluated on the scale positive-borderline-negative.
A total of 7962 sera samples were evaluated using three different methods-two types of ELISA tests and CLIA. Positive result was issued in a total of 62.6 percent of samples, but the results of individual laboratories varied widely from 55.5 to 70.8 percent. However, the same trend with the highest levels of antibodies in people born before beginning of vaccination was observed.
Data show significantly different results depending on the individual laboratories and the detection kits used. The underestimation of the proportion of positive results can cause problems in selecting individuals for revaccination with a live vaccine, which may fail in weakly positive individuals.
尽管自常规疫苗接种引入以来,全球麻疹发病率有所下降,但近年来其发病频率再次上升。本研究聚焦于捷克共和国奥洛穆茨地区在四个实验室分析的数据,并将所得结果与已发表的数据进行比较。
数据由各个实验室以匿名形式提供——检查时的年龄、性别和检测结果。样本于2018年6月至2019年9月期间采集,并按照阳性-临界-阴性标准进行评估。
共使用三种不同方法——两种酶联免疫吸附测定(ELISA)试验和化学发光免疫分析(CLIA)对7962份血清样本进行了评估。总共62.6%的样本检测结果呈阳性,但各个实验室的结果差异很大,从55.5%到70.8%不等。然而,观察到相同的趋势,即在疫苗接种开始前出生的人群中抗体水平最高。
数据显示,根据各个实验室和所使用的检测试剂盒不同,结果存在显著差异。阳性结果比例的低估可能会在选择进行活疫苗再接种的个体时引发问题,因为弱阳性个体接种可能会失败。